0001654954-17-008691.txt : 20170921
0001654954-17-008691.hdr.sgml : 20170921
20170921172807
ACCESSION NUMBER: 0001654954-17-008691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170919
FILED AS OF DATE: 20170921
DATE AS OF CHANGE: 20170921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASELAGE STEVE
CENTRAL INDEX KEY: 0001221599
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 171096398
MAIL ADDRESS:
STREET 1: 6300 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760333165
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE #2240
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE #2240
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2017-09-19
0001069308
Acer Therapeutics Inc.
ACER
0001221599
ASELAGE STEVE
222 THIRD STREET
SUITE #2240
CAMBRIDGE
MA
02142
true
Common Stock
2017-09-19
4
J
false
11905
A
11905
D
Nonqualified Stock Option (right to buy)
2.55
2017-09-19
4
J
false
21000
A
2025-10-19
Common Stock
21000
21000
D
Received in connection with the Issuer's business combination (the "Merger") with what was then known as "Acer Therapeutics Inc." ("Private Acer") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated June 30, 2017 among the Issuer, Opexa Merger Sub, Inc. and Private Acer, in exchange for 11,905 shares of common stock of Private Acer.
Received in connection with the Merger in exchange for an option to acquire 21,000 shares of common stock of Private Acer.
Option vests in eight equal quarterly installments beginning on October 19, 2015.
/s/ Daniel S. Clevenger, Attorney-in-Fact for Steve Aselage
2017-09-21